Pharma
-
GLP-1 Hormone Reshapes Diabetes and Obesity Care
A hormone first identified decades ago is now at the center of a medical shift in how doctors approach diabetes and obesity.…
-
FDA Approves New Schizophrenia Medication With Unique Mechanism
The U.S. Food and Drug Administration granted approval on September 15, 2024, for a new fixed-dose combination medication designed to treat schizophrenia.…
-
FDA Approves Lazertinib for Lung Cancer Patients
For patients with a common form of lung cancer, a new treatment option arrived in the United States on August 15, 2024.…
-
FDA Approves Lung Cancer Drug Lazertinib After 4-Year Lag
South Korea, August 16, 2024 — cyberinktimes.com — Almost four years after South Korean regulators gave it the green light, Lazertinib has…
-
Lazertinib Approved in US for Non-Small Cell Lung Cancer Treatment
In August 2024, the U.S. Food and Drug Administration granted approval for lazertinib, expanding the therapeutic arsenal against non‑small cell lung cancer…
-
FDA Approves Imetelstat for Treating Myelodysplastic Syndromes with Anemia
In a pivotal shift for the cancer treatment landscape, the US Food and Drug Administration (FDA) granted approval on June 15, 2024,…
-
FDA Approves Imetelstat for Myelodysplastic Syndromes
June 20, 2024 — cyberinktimes.com — The FDA approved a new cancer drug on June 15, 2024. It works by attacking the…
-
New Migraine Medication Offers Hope With Unique Treatment Approach
Migraine attacks often strike without warning, bringing intense pain, light sensitivity and nausea. Traditional acute treatments have been limited, and preventive regimens…
-
AbbVie Pays $10.1B for ImmunoGen ADC Platform
On a Wednesday in mid-November, AbbVie decided it would pay $10.1 billion for ImmunoGen. That is a lot of money for a…
-
FDA Approves New Oral Pill Zuranolone for Postpartum Depression
On August 15, 2023, the United States Food and Drug Administration granted approval to Zuranolone, a medication that will be marketed under…
-
FDA Approves Cancer Drug That Forces Immune Cells to Attack Tumors
/ HTML. So we need headings maybe and paragraphs . Must not add any extra info. Must keep facts: FDA approved Elranatamab…
-
Niraparib/abiraterone acetate EU-approved for prostate cancer
European Union, April 19, 2023 — cybernewschronicle.com — Niraparib/abiraterone acetate, a fixed-dose combination anti-cancer medication, has been approved for the treatment of…
-
Israeli Researchers Propose Losartan for COVID-19
Israel, March 18, 2020 — cyberinktimes.com — Losartan, a common blood pressure drug, is being proposed as a treatment for COVID-19. The…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
Amgen and AstraZeneca Combination Therapy Shows Unprecedented Survival Gains in Lung Cancer
-
Moderna’s mRNA Platform Enables Rapid Personalized Cancer Vaccines
-
Evaluating Skyrizi’s Efficacy and Market Position in Crohn’s Disease Care
-
How Personalized mRNA Vaccines Target Neoantigens to Beat Melanoma
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
Suze Orman: Why Medical Costs Demand an 8-Month Emergency Fund
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds













